-
1دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
المؤلفون: Tentori CA; Humanitas Clinical and Research Center-IRCCS & Department of Biomedical Sciences Humanitas University Milan Italy.; Comprehensive Cancer Centre, King's College London UK., Zhao LP; Hématologie seniors Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (APHP) Paris France.; INSERM UMR_S1160, Institut de Recherche Saint Louis Université Paris Cité Paris France., Tinterri B; Humanitas Clinical and Research Center-IRCCS & Department of Biomedical Sciences Humanitas University Milan Italy., Strange KE; Comprehensive Cancer Centre, King's College London UK.; Research Group of Molecular Immunology Francis Crick Institute London UK., Zoldan K; Department of Medicine 1, Haematology, Cellular Therapy, Hemostaseology and Infectious Diseases University Medical Center Leipzig Leipzig Germany., Dimopoulos K; Department of Clinical Biochemistry Bispebjerg and Frederiksberg Hospital Copenhagen Denmark.; Department of Pathology, Rigshospitalet Copenhagen University Hospital Copenhagen Denmark., Feng X; Hematology Branch, National Heart, Lung and Blood Institute Bethesda Maryland USA., Riva E; Humanitas Clinical and Research Center-IRCCS & Department of Biomedical Sciences Humanitas University Milan Italy., Lim B; Imperial College London London UK., Simoni Y; Université Paris Cité, CNRS, INSERM, Institut Cochin Paris France., Murthy V; Centre for Clinical Haematology, University Hospitals of Birmingham Birmingham UK., Hayes MJ; Cell & Developmental Biology Vanderbilt University School of Medicine Nashville Tennessee USA.; Pathology, Microbiology and Immunology, Vanderbilt University Medical Center Nashville Tennessee USA.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center Nashville Tennessee USA., Poloni A; Department of Clinical and Molecular Sciences Università Politecnica delle Marche Ancona Italy., Padron E; Moffitt Cancer Center, Malignant Hematology Department Tampa USA., Cardoso BA; Universidade Católica Portuguesa Faculdade de Medicina Portugal.; Universidade Católica Portuguesa, Centro de Investigação Interdisciplinar em Saúde Portugal., Cross M; Department of Medicine 1, Haematology, Cellular Therapy, Hemostaseology and Infectious Diseases University Medical Center Leipzig Leipzig Germany., Winter S; Medical Clinic I, University Hospital Carl Gustav Carus, TU Dresden Dresden Germany., Santaolalla A; Comprehensive Cancer Centre, King's College London UK., Patel BA; Hematology Branch, National Heart, Lung and Blood Institute Bethesda Maryland USA., Groarke EM; Hematology Branch, National Heart, Lung and Blood Institute Bethesda Maryland USA., Wiseman DH; Division of Cancer Sciences The University of Manchester Manchester UK.; The Christie NHS Foundation Trust Manchester UK., Jones K; Immunophenotyping Laboratory (Synnovis Analytics LLP) Southeast Haematological Malignancy Diagnostic Service, King's College Hospital London UK., Jamieson L; Immunophenotyping Laboratory (Synnovis Analytics LLP) Southeast Haematological Malignancy Diagnostic Service, King's College Hospital London UK., Manogaran C; Immunophenotyping Laboratory (Synnovis Analytics LLP) Southeast Haematological Malignancy Diagnostic Service, King's College Hospital London UK., Daver N; University of Texas MD Anderson Cancer Center Houston, Texas USA., Gallur L; Hematology Department, Vall d'hebron University Hospital, Vall d'hebron Institut of Oncology (VHIO) Vall d'Hebron Barcelona Hospital Campus Barcelona Spain., Ingram W; Department of Haematology University Hospital of Wales Cardiff UK., Ferrell PB; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center Nashville Tennessee USA.; Vanderbilt University Medical Center Nashville Tennessee USA., Sockel K; Medical Clinic I, University Hospital Carl Gustav Carus, TU Dresden Dresden Germany., Dulphy N; INSERM UMR_S1160, Institut de Recherche Saint Louis Université Paris Cité Paris France.; Laboratoire d'Immunologie et d'Histocompatibilité, Assistance Publique des Hôpitaux de Paris (APHP), Hôpital Saint-Louis Paris France.; Institut Carnot OPALE, Institut de Recherche Saint-Louis, Hôpital Saint-Louis Paris France., Chapuis N; Université Paris Cité, CNRS, INSERM, Institut Cochin Paris France.; Assistance Publique-Hôpitaux de Paris Centre, Hôpital Cochin Paris France., Kubasch AS; Department of Medicine 1, Haematology, Cellular Therapy, Hemostaseology and Infectious Diseases University Medical Center Leipzig Leipzig Germany., Olsnes AM; Section for Hematology, Department of Medicine Haukeland University Hospital Bergen Norway.; Department of Clinical Science Faculty of Medicine, University of Bergen Bergen Norway., Kulasekararaj A; Department of Haematology King's College Hospital, Denmark Hill London UK., De Lavellade H; Haematology Department Guy's and St Thomas NHS Trust London UK., Kern W; MLL Münchner Leukämielabor Munich Germany., Van Hemelrijck M; Comprehensive Cancer Centre, King's College London UK., Bonnet D; Hematopoietic Stem Cell Laboratory Francis Crick Institute London UK., Westers TM; Department of Hematology, Cancer Center Amsterdam Amsterdam University Medical Centers, location VU University Medical Center Amsterdam The Netherlands., Freeman S; Institute of Immunology and Immunotherapy University of Birmingham Birmingham UK., Oelschlaegel U; Medical Clinic I, University Hospital Carl Gustav Carus, TU Dresden Dresden Germany., Valcarcel D; Hematology Department, Vall d'hebron University Hospital, Vall d'hebron Institut of Oncology (VHIO) Vall d'Hebron Barcelona Hospital Campus Barcelona Spain., Raddi MG; Myelodysplastic Syndrome Unit, Hematology Division Azienda Ospedaliero-Universitaria Careggi, University of Florence Florence Italy., Grønbæk K; Department of Hematology, Rigshospitalet Copenhagen University Hospital Copenhagen Denmark.; Biotech Research and Innovation Center (BRIC) University of Copenhagen Copenhagen Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences University of Copenhagen Copenhagen Denmark., Fontenay M; Université Paris Cité, CNRS, INSERM, Institut Cochin Paris France.; Assistance Publique-Hôpitaux de Paris Centre, Hôpital Cochin Paris France., Loghavi S; University of Texas MD Anderson Cancer Center Houston, Texas USA., Santini V; Myelodysplastic Syndrome Unit, Hematology Division Azienda Ospedaliero-Universitaria Careggi, University of Florence Florence Italy., Almeida AM; Hematology Department Hospital da Luz Lisboa Lisboa Portugal.; Deanery Faculdade de Medicina, UCP Lisboa Portugal., Irish JM; Cell & Developmental Biology Vanderbilt University School of Medicine Nashville Tennessee USA.; Pathology, Microbiology and Immunology, Vanderbilt University Medical Center Nashville Tennessee USA.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center Nashville Tennessee USA., Sallman DA; Moffitt Cancer Center, Malignant Hematology Department Tampa USA., Young NS; Hematology Branch, National Heart, Lung and Blood Institute Bethesda Maryland USA., van de Loosdrecht AA; Department of Hematology, Cancer Center Amsterdam Amsterdam University Medical Centers, location VU University Medical Center Amsterdam The Netherlands., Adès L; Hématologie seniors Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (APHP) Paris France.; Université Paris Cité, CNRS, INSERM, Institut Cochin Paris France., Della Porta MG; Humanitas Clinical and Research Center-IRCCS & Department of Biomedical Sciences Humanitas University Milan Italy., Cargo C; Leeds Teaching Hospital Leeds UK., Platzbecker U; Department of Medicine 1, Haematology, Cellular Therapy, Hemostaseology and Infectious Diseases University Medical Center Leipzig Leipzig Germany., Kordasti S; Comprehensive Cancer Centre, King's College London UK.; Department of Clinical and Molecular Sciences Università Politecnica delle Marche Ancona Italy.; Haematology Department Guy's and St Thomas NHS Trust London UK.
مؤلفون مشاركون: i4MDS consortium
المصدر: HemaSphere [Hemasphere] 2024 May 15; Vol. 8 (5), pp. e64. Date of Electronic Publication: 2024 May 15 (Print Publication: 2024).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
-
4دورية أكاديمية
المؤلفون: Olsnes AM; Division of Hematology, Department of Medicine, Haukeland University Hospital and The University of Bergen, Bergen, Norway., Hatfield KJ, Bruserud Ø
المصدر: Journal of B.U.ON. : official journal of the Balkan Union of Oncology [J BUON] 2009 Sep; Vol. 14 Suppl 1, pp. S131-40.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: BAKIS Productions LTD Country of Publication: Cyprus NLM ID: 100883428 Publication Model: Print Cited Medium: Print ISSN: 1107-0625 (Print) Linking ISSN: 11070625 NLM ISO Abbreviation: J BUON Subsets: MEDLINE
مواضيع طبية MeSH: Chemokines/*physiology , Chemokines, CXC/*physiology , Leukemia, Myeloid, Acute/*therapy, Chemokines/genetics ; Chemokines, CC/genetics ; Chemokines, CC/physiology ; Chemokines, CXC/genetics ; Humans ; Interleukin-8/genetics ; Interleukin-8/physiology ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/physiopathology ; Neovascularization, Physiologic/physiology ; Receptors, Chemokine/genetics ; Receptors, Chemokine/physiology ; T-Lymphocytes/immunology
-
5دورية أكاديمية
المؤلفون: Olsnes AM; Division for Haematology, Department of Medicine, Haukeland University Hospital, Bergen, Norway. astrid.olsnes@med.uib.no, Ersvaer E, Ryningen A, Paulsen K, Hampson P, Lord JM, Gjertsen BT, Kristoffersen EK, Bruserud Ø
المصدر: British journal of haematology [Br J Haematol] 2009 Jun; Vol. 145 (6), pp. 761-74. Date of Electronic Publication: 2009 Apr 20.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Diterpenes/*therapeutic use , Leukemia, Myeloid, Acute/*drug therapy , NF-kappa B/*metabolism, Adult ; Aged ; Aged, 80 and over ; Cell Differentiation ; Chemokines/immunology ; Female ; Flow Cytometry ; Humans ; Leukemia, Myeloid, Acute/immunology ; Leukemia, Myeloid, Acute/metabolism ; Male ; Middle Aged ; NF-kappa B/analysis ; NF-kappa B/genetics ; Protein Kinase C/metabolism ; RNA Interference ; RNA, Small Interfering/pharmacology ; Statistics, Nonparametric ; Tumor Cells, Cultured
-
6دورية أكاديمية
المؤلفون: Reikvam H; Division for Hematology, Institute of Medicine, University of Bergen, Bergen, Norway., Olsnes AM, Gjertsen BT, Ersvar E, Bruserud Ø
المصدر: Critical reviews in oncogenesis [Crit Rev Oncog] 2009; Vol. 15 (1-2), pp. 1-41.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review
بيانات الدورية: Publisher: Begell House Country of Publication: United States NLM ID: 8914610 Publication Model: Print Cited Medium: Print ISSN: 0893-9675 (Print) Linking ISSN: 08939675 NLM ISO Abbreviation: Crit Rev Oncog Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Agents/*pharmacology , Leukemia, Myeloid, Acute/*metabolism , NF-kappa B/*metabolism , Signal Transduction/*physiology, Humans ; Leukemia, Myeloid, Acute/drug therapy ; NF-kappa B/antagonists & inhibitors
-
7دورية أكاديمية
المؤلفون: Olsnes AM; Division for Hematology, Department of Medicine, Haukeland University Hospital and The University of Bergen, Bergen, Norway., Ersvaer E, Ryningen A, Bruserud O
المصدر: Hematology (Amsterdam, Netherlands) [Hematology] 2008 Dec; Vol. 13 (6), pp. 329-32.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print Cited Medium: Internet ISSN: 1607-8454 (Electronic) Linking ISSN: 10245332 NLM ISO Abbreviation: Hematology Subsets: MEDLINE
مواضيع طبية MeSH: Leukemia, Myeloid, Acute/*complications , Pancytopenia/*chemically induced , Receptors, Chemokine/*analysis , T-Lymphocytes/*immunology, Adult ; Aged ; CD3 Complex ; Case-Control Studies ; Hematopoietic Stem Cell Transplantation ; Humans ; Leukemia, Myeloid, Acute/immunology ; Leukemia, Myeloid, Acute/therapy ; Middle Aged ; T-Lymphocytes/chemistry ; Transplantation, Homologous
-
8دورية أكاديمية
المؤلفون: Olsnes AM; Department of Medicine, Division for Hematology, Haukeland University Hospital Institute of Medicine and The University of Bergen, Bergen, Norway. oystein.bruserud@haukeland.no, Ryningen A, Ersvaer E, Bruserud Ø
المصدر: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research [J Interferon Cytokine Res] 2008 May; Vol. 28 (5), pp. 297-310.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 9507088 Publication Model: Print Cited Medium: Print ISSN: 1079-9907 (Print) Linking ISSN: 10799907 NLM ISO Abbreviation: J Interferon Cytokine Res Subsets: MEDLINE
مواضيع طبية MeSH: Blast Crisis/*pathology , Chemokine CCL17/*metabolism , Chemokine CCL22/*metabolism , Chemotaxis/*immunology , Dendritic Cells/*immunology , Leukemia, Myeloid, Acute/*pathology , T-Lymphocytes/*immunology, Aged ; Blast Crisis/immunology ; Cell Movement/drug effects ; Cell Survival/drug effects ; Cryopreservation ; Dendritic Cells/drug effects ; Dendritic Cells/pathology ; Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology ; Humans ; Immunocompetence/drug effects ; Interleukin-4/pharmacology ; Leukemia, Myeloid, Acute/immunology ; Membrane Proteins/pharmacology ; Middle Aged ; Phenotype ; Stem Cell Factor/pharmacology ; T-Lymphocytes/drug effects ; T-Lymphocytes, Regulatory/drug effects ; T-Lymphocytes, Regulatory/immunology ; Transforming Growth Factor beta1/pharmacology ; Tumor Cells, Cultured ; Tumor Necrosis Factor-alpha/pharmacology
-
9دورية أكاديمية
المؤلفون: Bruserud Ø; Division for Hematology, Department of Medicine, Haukeland University Hospital and The University of Bergen, Bergen, Norway. oystein.bruserud@haukeland.no, Ryningen A, Olsnes AM, Stordrange L, Øyan AM, Kalland KH, Gjertsen BT
المصدر: Haematologica [Haematologica] 2007 Mar; Vol. 92 (3), pp. 332-41.
نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
مواضيع طبية MeSH: Chemokines/*pharmacology , Leukemia, Myeloid/*classification, Acute Disease ; Adult ; Aged ; Aged, 80 and over ; Boronic Acids/pharmacology ; Bortezomib ; Cell Division/drug effects ; Cell Line, Tumor/drug effects ; Cell Line, Tumor/metabolism ; Chemokines/metabolism ; Chemotaxis/drug effects ; DNA Replication/drug effects ; Female ; Hematopoietic Cell Growth Factors/pharmacology ; Humans ; Leukemia, Myeloid/immunology ; Leukemia, Myeloid/metabolism ; Leukemia, Myeloid/pathology ; Male ; Middle Aged ; NF-kappa B/biosynthesis ; NF-kappa B/genetics ; Neoplasm Proteins/biosynthesis ; Neoplasm Proteins/genetics ; Pyrazines/pharmacology ; Receptors, Chemokine/biosynthesis ; Receptors, Chemokine/genetics ; Recombinant Fusion Proteins/pharmacology ; T-Lymphocytes/drug effects ; Tumor Stem Cell Assay